Evidence mapPaperPMID 42070189Full record

ArticleAngiogenesis2026

Neuropilin 1 (NRP1) conveys SEMA3A signals to restrict physiological angiogenesis.

Marco Spreafico, Elena Guzzolino, Francesca Fanuele, Gaia Gestri, Carlotta Tacconi, Sara Palermo, Matilde Tricco, Valeria Catroppa, Ayazhan Aiypova, Laura Denti and 3 more

Abstract read
In one paragraph

Article in Angiogenesis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marco SpreaficoDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Elena GuzzolinoDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Francesca FanueleDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Gaia GestriUCL Department of Cell and Developmental Biology, University College London, Gower Street, London, WC1E 6BT, UK.
Carlotta TacconiDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Sara PalermoDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Matilde TriccoDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Valeria CatroppaDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Ayazhan AiypovaDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy.
Laura DentiUCL Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK.
Caroline Pellet-ManyDepartment of Comparative Biomedical Sciences, Royal Veterinary College, Royal College Street, London, NW1 0TU, UK.
Christiana RuhrbergUCL Institute of Ophthalmology, University College London, 11-43 Bath Street, London, EC1V 9EL, UK.
Alessandro FantinDepartment of Biosciences, University of Milan, Via G. Celoria 26, 20133, Milan, Italy. alessandro.fantin@unimi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The class 3 semaphorin SEMA3A is a secreted glycoprotein that serves as an evolutionary conserved axon repellent with proposed vascular functions. In mice, SEMA3A is dispensable for developmental brain, limb or trunk blood vessel patterning, but restricts vessel branching in the zebrafish embryo trunk. Whereas neuropilin 1 (NRP1) is thought to be the SEMA3A receptor in the mouse, prior reports identified Plexin D1 as the Sema3a receptor in zebrafish trunk vessel patterning, with previous knockdown and knockout studies yielding contradictory results on Nrp1 requirement for vessel patterning in zebrafish. To resolve these discrepancies, we have refined the prior knockdown strategy to limit off target effects and generated mutant zebrafish embryos lacking both Nrp1a and Nrp1b paralogues to show that Nrp1 restricts trunk vessel patterning in a Sema3a-dependent manner. In agreement, we found that NRP1 is required in human endothelial cells for SEMA3A-induced repulsion. Moreover, we show that SEMA3A action via NRP1 does not involve the splicing regulation of FLT1, previously proposed to act downstream of Plexin D1. Instead, sustained NRP1 activation independent of SEMA3A increases the expression of the anti-angiogenic soluble FLT1 (sFLT1), establishing a feedback mechanism to limit endothelial proliferation. Together, these findings demonstrate a dual role for NRP1 in shaping physiological vascular morphogenesis. Thus, NRP1 mediates repulsive SEMA3A cues in endothelial cells, in analogy to its role in axon guidance, and further restricts angiogenesis by promoting the release of sFLT1 in a SEMA3A-independent manner.

Indexed as

Neovascularization, PhysiologicNeuropilin-1Semaphorin-3ASignal TransductionZebrafish ProteinsAnimalsEndothelial CellsHumansZebrafishNeuropilin-1Semaphorin-3AZebrafish ProteinsAngiogenesisHUVECNeuropilin 1SEMA3AZebrafish

Identifiers

PMID42070189
PMCPMC13136202

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.